| Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination D Grupel, S Gazit, L Schreiber, V Nadler, T Wolf, R Lazar, L Supino-Rosin, ... Vaccine 39 (38), 5337-5340, 2021 | 36 | 2021 |
| COVID-19 in a Subset of Hospitalized Children in Israel S Ben-Shimol, G Livni, O Megged, D Greenberg, D Danino, I Youngster, ... Journal of the Pediatric Infectious Diseases Society 10 (7), 757-765, 2021 | 35 | 2021 |
| A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report G Perez, T Banon, S Gazit, SB Moshe, J Wortsman, D Grupel, A Peretz, ... MedRxiv, 2021.03. 06.21253051, 2021 | 29* | 2021 |
| Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with omicron variant COVID‐19 T Shafat, D Grupel, T Porges, I Levi, Y Yagel, L Nesher British Journal of Haematology, 2022 | 13 | 2022 |
| Efficacy and long‐term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel O Kalchiem‐Dekel, D Grupel, L Bouchnik, E Sikuler, G Ben‐Yakov Journal of gastroenterology and hepatology 30 (12), 1782-1787, 2015 | 9 | 2015 |
| Public and animal health risks associated with spillover of Brucella melitensis into dairy farms S Bardenstein, D Grupel, SE Blum, Y Motro, J Moran-Gilad Microbial genomics 9 (4), 001014, 2023 | 8 | 2023 |
| Case report: imported melioidosis from Goa, India to Israel, 2018 T Brosh-Nissimov, D Grupel, S Abuhasira, H Leskes, S Lazar, U Elia, ... The American Journal of Tropical Medicine and Hygiene 101 (3), 580, 2019 | 5 | 2019 |
| Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after … T Brosh-Nissimov, A Tzur, D Grupel, A Cahan, N Ma’aravi, M Heled-Akiva, ... Annals of Clinical Microbiology and Antimicrobials 22 (1), 62, 2023 | 4 | 2023 |
| Prevalence and Characteristics of Carriage of Neisseria meningitidis Among Young Israeli Adults N Sofer-Sali, D Roif-Kaminsky, Y Motro, B Khalfin, E Avramovich, I Galor, ... Open Forum Infectious Diseases 9 (10), ofac482, 2022 | 4 | 2022 |
| Escape room—the next generation of problem-based learning? D Grupel, E Wennstroem, J Moran-Gilad Clinical Microbiology and Infection 28 (6), 768-770, 2022 | 4 | 2022 |
| The association between SARS‐CoV‐2 infection and late pregnancy loss YG Paz, S Shiloh, T Brosh‐Nissimov, D Grupel, N Sorek, T Kustin, A Stern, ... International Journal of Gynaecology and Obstetrics 157 (1), 208, 2022 | 4 | 2022 |
| Performance of echinococcosis serology is associated with disease endemicity, hydatid cyst location, eosinophilia, imaging finding, and treatment M Shmueli, J Van Buren, O Sagi, D Grupel, A Sheves, Z Assi, ... Acta Parasitologica 69 (1), 233-241, 2024 | 2 | 2024 |
| Effect of same-arm versus cross-arm administration of sequential doses of BNT162b2 on short-term vaccine effectiveness—a retrospective cohort study D Grupel, Y Pasternak, Y Schonmann Clinical Microbiology and Infection 29 (4), 540. e1-540. e7, 2023 | 2 | 2023 |
| The role of Staphylococcus lugdunensis as a pathogen in children: a multicentre retrospective study N Hurvitz, LOS Cahan, I Gross, D Grupel, O Megged, Y Pasternak, ... Journal of Medical Microbiology 70 (5), 001357, 2021 | 2 | 2021 |
| The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study D Shasha, D Grupel, O Treigerman, G Prajgrod, Y Paran, D Hacham, ... Clinical Microbiology and Infection 30 (1), 130-136, 2024 | 1 | 2024 |
| Clinical characteristics of SARS-CoV-2 vaccine-related acute appendicitis E Quint, I Kukeev, I Hazan, D Grupel, O Dukhno, A Osyntsov, G Sebbag, ... Canadian Journal of Surgery 66 (3), E304, 2023 | 1 | 2023 |
| Aspergillus wound infection in an immune-competent patient–A case report E Quint, I Kukeev, H Glinter, A Osyntsov, G Barsky, A Vakhrushev, ... Clinical Infection in Practice 15, 100146, 2022 | 1 | 2022 |
| Varicella-Zoster Virus–Induced Neurologic Disease After COVID-19 Vaccination: A Multicenter Observational Cohort Study M Elbaz, T Hoffman, D Yahav, S Dovrat, N Ghanem-Zoubi, A Atamna, ... Open Forum Infectious Diseases 11 (6), 2024 | | 2024 |
| An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab T Shafat, D Grupel, T Porges, R Abuhasira, A Belkin, O Deri, Y Oster, ... Cancer Medicine 13 (3), e6997, 2024 | | 2024 |
| 2654. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge T Shafat, D Grupel, T Porges, A Belkin, O Deri, Y Oster, S Zahran, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2265, 2023 | | 2023 |
Jacob Moran GiladBen-Gurion University of the NegevVerified email at post.bgu.ac.il
